ATE202106T1 - Neue als immunsuppressiva nützliche karbozyklische adenosinanaloge - Google Patents

Neue als immunsuppressiva nützliche karbozyklische adenosinanaloge

Info

Publication number
ATE202106T1
ATE202106T1 AT91115485T AT91115485T ATE202106T1 AT E202106 T1 ATE202106 T1 AT E202106T1 AT 91115485 T AT91115485 T AT 91115485T AT 91115485 T AT91115485 T AT 91115485T AT E202106 T1 ATE202106 T1 AT E202106T1
Authority
AT
Austria
Prior art keywords
immunosupressants
adenosine analogues
analogues useful
carbocyclic adenosine
new carbocyclic
Prior art date
Application number
AT91115485T
Other languages
English (en)
Inventor
David R Borcherding
Iii Carl K Edwards
Ronald E Esser
Douglas L Cole
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE202106T1 publication Critical patent/ATE202106T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT91115485T 1990-09-14 1991-09-12 Neue als immunsuppressiva nützliche karbozyklische adenosinanaloge ATE202106T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58228090A 1990-09-14 1990-09-14
US74817291A 1991-08-23 1991-08-23

Publications (1)

Publication Number Publication Date
ATE202106T1 true ATE202106T1 (de) 2001-06-15

Family

ID=27078528

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91115485T ATE202106T1 (de) 1990-09-14 1991-09-12 Neue als immunsuppressiva nützliche karbozyklische adenosinanaloge

Country Status (19)

Country Link
EP (1) EP0475411B1 (de)
JP (1) JP3099280B2 (de)
KR (1) KR100249111B1 (de)
CN (1) CN1031132C (de)
AR (1) AR247566A1 (de)
AT (1) ATE202106T1 (de)
AU (1) AU647822B2 (de)
CA (1) CA2051012C (de)
DE (1) DE69132632T2 (de)
DK (1) DK0475411T3 (de)
ES (1) ES2158840T3 (de)
FI (1) FI102755B (de)
GR (1) GR3036577T3 (de)
HU (1) HU209304B (de)
IE (1) IE913247A1 (de)
IL (1) IL99466A (de)
NO (1) NO179908C (de)
NZ (1) NZ239750A (de)
PT (1) PT98943B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470857A (en) * 1990-09-14 1995-11-28 Marion Merrell Dow Inc. Carbocyclic nucleoside analogs useful as immunosuppressants
AU642526B2 (en) * 1990-09-14 1993-10-21 Marion Merrell Dow Inc. Method of immunosuppression using cyclopentenyl substituted nucleoside analogs and compositions thereof
CA2084222C (en) * 1991-12-06 2004-04-06 David R. Borcherding Novel trans cyclopentanyl purine analogs useful as immunosuppressants
US5723466A (en) * 1991-12-06 1998-03-03 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5817672A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5817661A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5817660A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5292513A (en) * 1992-05-18 1994-03-08 Anthony G. Gristina Method for nonspecific cellular immune stimulation
BR9307646A (pt) 1992-12-17 1999-05-25 Pfizer Pirrolopirimidinas como antagonistas de crf
AU677851B2 (en) 1993-06-21 1997-05-08 Merrell Pharmaceuticals Inc. Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
CN1137274A (zh) * 1993-11-12 1996-12-04 默里尔药物公司 用作免疫抑制剂的6-氧代-核苷
TW282470B (de) * 1993-11-18 1996-08-01 Ajinomoto Kk
ES2109796T3 (es) * 1994-05-03 1998-01-16 Ciba Geigy Ag Derivados de pirrolopirimidilo con efecto antiproliferante.
TW574214B (en) * 1994-06-08 2004-02-01 Pfizer Corticotropin releasing factor antagonists
US6403599B1 (en) 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
US6956047B1 (en) 1995-06-06 2005-10-18 Pfizer Inc. Corticotropin releasing factor antagonists
US7125880B1 (en) 1995-06-06 2006-10-24 Pfizer Inc. Corticotropin releasing factor antagonists
CA2397633A1 (en) 2000-01-18 2001-07-26 Pfizer Products Inc. Corticotropin releasing factor antagonists
CN1871240B (zh) * 2003-08-26 2012-11-07 帝人制药株式会社 吡咯并嘧啶酮衍生物
US8945505B2 (en) 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551428A (en) * 1956-02-10 1970-12-29 Ciba Geigy Corp New 1- (or 2-) substituted 4-mercapto-pyrazolo(3,4-d)pyrimidines
US3917837A (en) * 1974-10-21 1975-11-04 American Cyanamid Co Method of using trans-2-(6-amino-9H-purin-9-yl)-cyclopentanol
US4076711A (en) * 1976-04-05 1978-02-28 Schering Corporation Triazolo [4,5-d]-pyrimidines
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4386093A (en) * 1981-09-16 1983-05-31 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services (±)3-Deazaaristeromycin and uses
IN164556B (de) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
US4859677A (en) * 1987-04-17 1989-08-22 University Of Kansas Nucleoside analogues having antiviral activity
US4782062A (en) * 1987-05-11 1988-11-01 Merck & Co., Inc. 9-(2-hydroxymethyl)cycloalkylmethyl) guanines
IL86381A0 (en) * 1987-05-19 1988-11-15 Nippon Kayaku Kk Oxetanocins and pharmaceutical compositions containing the same
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds

Also Published As

Publication number Publication date
KR100249111B1 (ko) 2000-08-01
FI914319A0 (fi) 1991-09-13
JP3099280B2 (ja) 2000-10-16
FI102755B1 (fi) 1999-02-15
NO913625L (no) 1992-03-16
NO913625D0 (no) 1991-09-13
KR920006357A (ko) 1992-04-27
HU912961D0 (en) 1992-01-28
DK0475411T3 (da) 2001-10-01
AU8372991A (en) 1992-03-19
NO179908B (no) 1996-09-30
IE913247A1 (en) 1992-02-25
PT98943B (pt) 1999-02-26
DE69132632T2 (de) 2002-04-18
IL99466A (en) 1996-07-23
GR3036577T3 (en) 2001-12-31
FI914319L (fi) 1992-03-15
HU209304B (en) 1994-04-28
AR247566A1 (es) 1995-01-31
CN1031132C (zh) 1996-02-28
NZ239750A (en) 1994-02-25
ES2158840T3 (es) 2001-09-16
PT98943A (pt) 1992-07-31
CA2051012C (en) 2002-04-02
EP0475411A1 (de) 1992-03-18
JPH04270282A (ja) 1992-09-25
NO179908C (no) 1997-01-08
FI102755B (fi) 1999-02-15
DE69132632D1 (de) 2001-07-19
AU647822B2 (en) 1994-03-31
EP0475411B1 (de) 2001-06-13
IL99466A0 (en) 1992-08-18
CA2051012A1 (en) 1992-03-15
CN1059909A (zh) 1992-04-01
HUT59138A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
FI924299L (fi) Dambinda eller inkontinensskydd
FI901903A7 (fi) Viruksenvastaisia aineita
DE69132632D1 (de) Neue als Immunsuppressiva nützliche karbozyklische Adenosinanaloge
FI931172L (fi) Vatten- och/eller oljeogenomslaepplig taetningsmatta
FI930841A7 (fi) Kombinerad kontroll- och reglerventil foer vaetskor eller gaser
FI933713L (fi) Taeppande eller taetande akrylkomposition
FI933421L (fi) Flerskiktsinloppslaoda foer en pappersmaskin eller dylik
FI940167A0 (fi) Puriinijohdannaisia
FI925957A0 (fi) Styranordning foer en eller flera arbetspunkter
FI925930L (fi) En kosmetisk eller dermatologisk blandning innehaollande en diolester
FI934614A0 (fi) Understoed foer lastlucka eller liknande
FI932970A0 (fi) Betongtransportblandare eller liknande
DE69331227D1 (de) Radiergummi
FI935253L (fi) Granatkastare foersedd med en eller flera eldroer
FI922855L (fi) Laett foerslutningsbar paose eller saeck
KR950703757A (ko) 양성-작용 포토레지스트 조성물(posivive-working pothoresist composition)
FI961105L (fi) Difluoristatoniviruksen vastaisia analogeja
KR910008699U (ko) 보조 정수기
FI934558L (fi) Lastnings- och/eller lossningsanordning foer faerja
KR940014625U (ko) 전침기
FR2646165B3 (fr) Peinture
FI934560A0 (fi) Lastnings- och/eller lossningsanordning foer faerja
FI931379A0 (fi) Foerbaettringar i eller i samband med mobilradiokommunikationssystem
FI496U1 (fi) Skyddskaopa foer broedlaoda eller liknande
FI450U1 (fi) Saekringssockel eller radsaekring

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee